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The combination of OCT4 expression and short-term exposure to reprogramming media induces a state of transcriptional
plasticity in human fibroblasts, capable of responding to changes in the extracellular environment that facilitate direct cell
fate conversion toward lineage specific progenitors. Here we reveal that continued exposure of OCT4-induced plastic human
fibroblasts to reprogramming media (RM) is sufficient to induce pluripotency. OCT4-derived induced pluripotent stem cell
(iPSCOCT4) colonies emerged after prolonged culture in RM, and formed independently of lineage specific progenitors. Human
iPSCOCT4 are morphologically indistinguishable from conventionally derived iPSCs and express core proteins involved in
maintenance of pluripotency. iPSCOCT4 display in vivo functional pluripotency as measured by teratoma formation consisting of
the three germ layers, and are capable of targeted in vitro differentiation. Our study indicates that acquisition of pluripotency
is one of multiple cell fate choices that can be facilitated through environmental stimulation of OCT4-induced plasticity, and
suggests the role of other reprogramming factors to induce pluripotency can be substituted by prolonged culture of plastic
fibroblasts.
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Foundational cell fate reprogramming studies revealed ectopic
expression of pluripotency-associated transcription factors (TF)
OCT4, SOX2, KLF4, and c-MYC (OSKM) or OCT4, SOX2, NANOG,
LIN28 (OSNL) in human fibroblasts (hFibs) cultured in pluripo-
tent supportive conditions was sufficient for generation of
induced pluripotent stem cells (iPSCs) possessing phenotypic,
molecular, and functional characteristics akin to embryonic
stem cells (ESCs) (Takahashi et al., 2007; Yu et al., 2007). A
multitude of reprogramming cocktails and methodologies have
since been demonstrated to yield iPSCs from a range of adult
cell types (Theunissen and Jaenisch, 2014). Early modifications
revealed ectopic expression of SKM could be functionally
replaced by expression of structural homologs (Nakagawa et
al., 2008) or chemical compounds (Li et al., 2011; Zhu et al.,
2010), and altogether bypassed if they were endogenously
expressed in starting cell types (Eminli et al., 2008; Giorgetti et
al., 2009; Kim et al., 2009). More recently, groups have
identified that Nr5a2 (Heng et al., 2010), E-cadherin (Redmer
et al., 2011) and Gata3 (Montserrat et al., 2013; Shu et al.,
2013) are capable of substituting for Oct4 when expressed with
SKM; while others have replaced OS with Sall4 and Esrrb in
combination with NL (Buganim et al., 2014). Furthermore,
complete replacement of ectopic expression of OSKM has
been achieved using miR302/367 expression in combination
with Hdac2 suppression (Anokye-Danso et al., 2011), and
a combination of seven small-molecule compounds in the
mouse system (Hou et al., 2013). However, despite these
advances, a substitute that definitively replaces Oct4's func-
tional activity and activates its gene targets in the absence of
other reprogramming factors has not been identified. As such,
OCT4's activity is indispensible for induction and maintenance
of pluripotency (Orkin et al., 2008; Sterneckert et al., 2012).
Further supporting this concept, ectopic expression of high
performance Oct4-VP16 transactivation domain fusion protein
in mouse embryonic fibroblasts (MEF) is the only example
of single factor reprogramming to achieve germline competent
iPSCs without the addition of small molecules, miRNA, or
ectopic/endogenous support by additional pluripotent factors
(Wang et al., 2011).
Using similar cellular reprogramming principles, two para-
digms exist toward achieving cell fate conversion. One
approach relies on forced expression of lineage-specific TFs to
facilitate lineage conversions (Lujan et al., 2012; Vierbuchen et
al., 2010). The alternative focuses on inducing an unstable or
plastic cell state, demarcated by activation of multiple lineage
specific gene expression programs, that is capable of
responding to environmental cues (R. Mitchell et al., 2014;
Orkin and Hochedlinger, 2011). Strategies using short-term
exposure toOSKM (Efe et al., 2011; Kimet al., 2011), OCT4with
small molecule substitutes of SKM (Wang et al., 2014; Zhu et
al., 2014), and OCT4 alone (R. Mitchell et al., 2014; R. R.
Mitchell et al., 2014; Szabo et al., 2010) in combination with
reprogramming media (RM) have been employed toward
achieving a cell state that responds to environmental cues.
However, these approaches are molecularly distinct as the
addition of pluripotency factors SKM convolutes plasticity
induction by up-regulating early development and pluripotency
genes (Maza et al., 2014; R. Mitchell et al., 2014), indicating
that OCT4 alone in combinationwith short-term exposure to RM
is minimally sufficient to induce plasticity (R. Mitchell et al.,2014). Accordingly, OCT4-induced plastic cells are capable
of responding to environmental instruction toward derivation of
neural and hematopoietic progenitors without traversing
pluripotency (R. R. Mitchell et al., 2014; Szabo et al., 2010).
Although molecular/functional evidence indicates that tran-
scriptional hallmarks of iPSCs are not observed in OCT4 plastic
cells during short-term exposure to RM, whether continued
culture in conditions known to support pluripotency is sufficient
to up-regulate these programs remains to be elucidated.
Given that OCT4 activity and RM is minimally required to
induce plasticity, and that this combination is also indispensible
in the multitude of methodologies described above to achieve
pluripotency reprogramming, we asked whether OCT4-induced
plasticity was sufficient for pluripotency acquisition. To this
end, we induced plasticity in human fibroblasts using OCT4 and
short-term exposure to RM. Plastic fibroblasts were subjected
to continued maintenance in pluripotent-supportive repro-
gramming media toward further influencing pluripotency
acquisition. Using a combination of morphological, molecular,
immunophenotypic, and functional assessments, we provide
evidence that our deconvoluted OCT4-induced plasticity
approach in combination with continued exposure to pluripo-
tent supportive conditions is sufficient for inducing bona fide
pluripotency in adult human fibroblasts.
Materials and methods
Human PSC and primary cell culture
Human dermal adult forearm biopsies (5 × 5 mm) were
obtained from consenting donors in accordance with Research
Ethics Board-approved protocols at McMaster University;
primary cultures were established as described (Villegas and
McPhaul, 2005). Primary human fibroblasts derived from
breast dermal tissue were obtained from ScienCell Research
Laboratories. All hFibs were cultured in hFibmedia [DMEMwith
10% v/v fetal bovine serum (Neonatal Bovine Serum, HyClone),
1% v/v non-essential amino acid (NEAA; Gibco), and 1 mM
L-glutamine (Gibco)].
iPSCOCT4 were derived on Matrigel (BD Biosciences)
in reprogramming media (RM) [DMEM/F12 (Gibco) with
20% Knockout Serum Replacement (Gibco), 100 μM
β-mercaptoethanol, 100 μM nonessential amino acid (Gibco),
1 mM L-glutamine (Gibco) supplemented with 16 ng/ml basic
fibroblast growth factor (bFGF) and 30 ng/mL insulin-like
growth factor (IGFII)]; and adapted to and cultured in mouse
embryonic fibroblast conditionedmedia (MEFCM) supplement-
ed with 10 ng/ml bFGF to stabilize pluripotency and enable
colony expansion. iPSCOSNL were cultured on Matrigel (BD
Biosciences) in MEFCM supplemented with 10 ng/ml bFGF.
Cells were fed with fresh medium daily and confluent cultures
were mechanically or enzymatically passaged every 5–7 days
using 1 mg/ml Collagenase IV (Invitrogen).
Preparation of lentiviral vectors
pSIN-EF1α-OCT4-Puro plasmid developed by James A. Thomson
(University of Madison-Wisconsin) and PL-SIN-EF1α-eGFP-Puro
developed by James Ellis (University of Toronto) were obtained
from Addgene. Virus containing plasmid was produced from
HEK 293FT Cells with 2nd generation pMD2.G and psPAX2
223Acquisition of pluripotency in OCT4-plastic Fibspackaging plasmids. Viral supernatant was harvested 72h after
transfection and concentrated by ultracentrifugation.
Lentiviral transduction of primary human fibroblasts
Human adult dermal fibroblasts (104 adherent cells per well of
a 12-well plate seeded on Matrigel the day before transduc-
tion) were incubated for 24 h with concentrated OCT4 or eGFP
lentiviral vector in 0.5 mL hFib medium in the presence of
8 μg/ml polybrene (Sigma Aldrich). After 24 h of incubation,
2 mL of RM was added to the well. Following a further 24 h of
incubation, lentiviral transduction conditions were replaced
entirely with RM. Cells were maintained in this condition for
prolonged culture with media changes and removal of areas of
overgrown fibroblasts as necessary. iPSC colonies emerged
between days 45 and 93, and were mechanically isolated and
further expanded in MEFCM conditions.
Teratoma formation
To assess the development potential of iPSCs in vivo, iPSCs
were collected by collagenase IV treatment and injected into
the left testicle of NOD/SCID mice (approximately one well of
a 6 well plate of 80% confluence for each mouse). At eight to
ten weeks, teratomas were harvested, dissected and fixed
with 4% paraformaldehyde. Samples were embedded in
paraffin and processed with hematoxylin and eosin staining.
hEB formation and hematopoietic differentiation
Human embryoid bodies (hEBs) were generated by
suspension culture as previously described (Hong et al.,
2010). Medium was changed with the hEB differentiation
medium supplemented with hematopoietic growth factors
(hGFs) as follows: 50 ng/ml granulocyte colony stimulating
factor (G-CSF; Amgen, Inc.), 300 ng/ml stem cell factor
(SCF; Amgen), 10 ng/ml interleukin-3 (IL-3; R&D systems),
10 ng/ml interleukin-6 (IL-6; R&D systems), 25 ng/ml BMP4
(R&D systems), and 300 ng/ml Flt-3 ligand (Flt-3L: R&D
systems). hEBs were cultured for 16 days and medium was
changed every three days. hEBs were enzymatically digested
using Collagenase B, and single cells were collected. 10,000
cells were plated in Methocult H4434 medium. Colony
forming units were identified and quantified on day 16.
Flow cytometry
Human Fibs and iPSCs were dissociated to single cell sus-
pensions using TrypLE Express. Cells were stained using the
following antibodies: CD34-PE or -FITC (Miltenyi Biotech),
CD45-APC (Miltenyi Biotech) for hematopoietic EB differen-
tiation experiments. For pluripotent analysis, cells were
analyzed for the presence of SSEA3-PE and TRA-1-60-Alexa
Fluor 647 (BD Pharmingen) for live cell surface markers. For
detection of intracellular pluripotent transcription factors
cells were fixed and permeabilized using the BD Cytofix/
Cytoperm kit. Cells were incubated overnight at 4 °C with
conjugated antibodies OCT4-Alexa Fluor 488, SOX2-Alexa
Fluor 647 and NANOG-PE (BD Pharmingen). Flow cytometric
analysis was performed using the BD LSRII Flow Cytometerwith BD FACSDiva software and analyzed with FlowJo
software (Tree Star Inc). Fluorescence activated cell sorting
(FACS) was performed using BD FACSAria II cell sorter.
Real-time quantitative reverse transcription poly-
merase chain reaction
Total RNA was extracted from Fib, FibOCT4, whole iPSC cul-
tures and FACS-isolated TRA-1-60+ iPSCs using the RNeasy kit
(Qiagen), and cDNA was generated using qScript cDNA
SuperMix (Quanta BioSciences). Oligonucleotides were de-
signed for the detection of OCT4 (total, endogenous and
exogenous), SOX2, NANOG and GAPDH (Table S1). RT-qPCR
was performed on the BioRad CFX96 for 40 cycles for all
marker genes. Relative gene expression was calculated using
the ΔΔCt method. Endogenous GAPDH housekeeping gene
was used for normalization.
Immunocytochemistry
Cells were washed once with 1×PBS containing Calcium and
Magnesium (Lonza) then fixed with 2% paraformaldehyde
using the BD Cytofix fixation buffer. Cells were stained with
SSEA3 or TRA-1-60 antibodies (BD Biosciences), and coun-
terstained with DAPI.
PCR for provirus integration
Genomic DNA was extracted from 5 × 105 hFibs and iPSCOCT4
using the Qiagen DNeasy Blood & Tissue Kit. To demonstrate the
presence or absence of transgenes in iPSCOCT4 and parent Fibs,
primers specific to each transgene and IRES sequencewere used
to amplify the provirus. Primer sets were designed specifically
to amplify OCT4, SOX2, LIN28, NANOG, KLF4, and cMYC
provirus. pSIN4-EF2-O2S, pSIN4-EF2-N2L, and pSIN-EF2-K2M
plasmids were used for positive controls. Primer sequences
are indicated in Table S2. PCR reactions were carried out using
Thermo Maxima Hot Start Taq DNA Pol. Initial denaturation at
95 °C (4 min) was followed by 35 cycles of denaturation at
95 °C (30 s), annealing at 60 °C (30 s), and elongation at 72 °C
(50 s), followed by a final elongation at 72 °C (5 min).
DNA fingerprinting
To confirm the dermal and breast fibroblast origins of iPSCOCT4
lines, restriction fragment length polymorphism (RFLP) anal-
ysis was performed in the Centre for Applied Genomics
Genetic Analysis Facility at SickKids Hospital (Toronto).
Array comparative genomic hybridization
Array comparative genomic hybridization (aCGH) was per-
formed by the Princess Margaret Genomic Centre (University
Health Network, Toronto) using an Agilent human genome CGH
4 × 44Kmicroarraywith CY3/CY5-labeled genomic DNA isolated
from TRA-1-60+ iPSCOCT4 and sex-matched reference DNA. Data
was analyzed on Partek Genomics Suite (v6.6) using the genome
copy number segmentation algorithm on log2 ratios converted
to copy number, with parameters set to: 15 minimum genomic
224 K.R. Salci et al.markers, 0.001 P-value threshold, 0.5 signal to noise ratio, and
diploid copy number range from 1.5 to 2.5.
Results
Continued exposure of plastic human fibroblasts to
pluripotent supportive conditions is sufficient for
the generation of iPSCs
Plastic human fibroblasts (hFibs) generated through ectopic
expression of OCT4 and short-term exposure to reprogramming
media (RM) are capable of responding to lineage-specificculture conditions toward direct conversion to hematopoietic
and neural progenitor cells without first initiating or establish-
ing pluripotency (R. R. Mitchell et al., 2014; Szabo et al., 2010).
Despite the lack of evidence that OCT4 plastic cells induce
early transcriptional hallmarks of iPSCs, we asked whether
pluripotency could be acquired through continued culturing
of OCT4 plastic cells in pluripotent supportive conditions.
Accordingly, hFibs were transduced with OCT4 (hFibOCT4)
and cultured in RM to induce plasticity (Figs. S1A and B) (R.
Mitchell et al., 2014). Consistent with our previous findings,
hFibOCT4 morphologies transitioned from bipolar-elongated to
compact-cuboidal, and this transition was dependent on the
combination of OCT4 and RM (Fig. S1C), suggesting that
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addition to predictive morphological features, total popula-
tions of plastic hFibOCT4 have been identified by their
acquisition of lineage specific gene expression profiles (R.
Mitchell et al., 2014) and by expression of lineage-specific
proteins (R. Mitchell et al., 2014; Szabo et al., 2010). For
example, expression of the pan-hematopoietic marker CD45
(Woodford-Thomas and Thomas, 1993) identifies a subset of
plastic cells in RM that are capable of responding to hema-
topoietic culture conditions and undergoing direct conversion
to the hematopoietic lineage (R. Mitchell et al., 2014; Szabo et
al., 2010). To further corroborate our morphological assess-
ment that plasticity had been achieved in our current study, we
performed flow cytometric analyses on total cell cultures at
Day 24 (Fig. 1A) using CD45 expression as a marker of plasticity
induction. Flow cytometric analyses revealed CD45 expression
on a subpopulation of cells (Fig. 1B), further indicating that
plasticity had been achieved. Moreover, we confirmed that
plastic hFibOCT4 were devoid of pluripotent markers SSEA3 and
TRA-1-60 at this time (Fig. 1B) (Takahashi et al., 2007). Having
confirmed that OCT4 plasticity had been induced, we con-
tinued to culture FibOCT4 in RM, also known to support pluri-
potency, and monitored these cultures for the emergence of
iPSC-like cells. After continued maintenance in RM ranging
from 45 to 93 days, flat dense colonies of cells with large nuclei
and scant cytoplasm resembling iPSCs were observed (Figs. 1C,
S1D and E). Flow cytometric and immunocytochemistry ana-
lyses revealed that these colonies expressed pluripotent mar-
kers SSEA3 and TRA-1-60 (Figs. 1D and E). In contrast, we did
not detect the emergence of TRA-1-60+ colonies from mechan-
ically isolated cultures of CD45+ plastic fibs cultured in RM for
the same period of time (Figs. S2A and B), suggesting that
CD45+ plastic fibs were not a reprogramming intermediate on
the path to iPSCs (Szabo et al., 2010). Next, we attempted
to expand SSEA3+TRA-1-60+ colonies through clonal isolation
and maintenance in RM. However, these conditions were not
conducive to expansion, resulting in cultures that did not
meet our morphological standards for PSC cultures (similar
to Fig. 1F) (Bendall et al., 2007; Lee et al., 2013). In an effort
to assess if pluripotency could be stabilized within these
cells toward facilitating clonal expansion in the absence of
mouse embryonic fibroblasts (MEF), we passed FibOCT4-derived
SSEA3+TRA-1-60+ colonies evenly into either RM or MEF
conditioned medium (MEFCM) supplemented with bFGF
(Bendall et al., 2007). Culture in MEFCM resulted inFigure 1 Continued exposure of OCT4 plastic human fibroblasts to plu
iPSCs.(A) Representative images of hFibOCT4 culture maintained in
image on right) that resemble plastic hFibs capable of respondin
conversion to the hematopoietic lineage suggests that plasticity has
analysis plots of total dissociated hFibOCT4 cultures reveal the presen
(C) Representative images of an emerging iPSC-like colony (left imag
origin (center and right image). Enlarged region of highlighted area (c
right. Scale bars represent 100 μm. (D) Flow cytometric analysis
presence of SSEA3+ and TRA-1-60+ cells. (E) SSEA3 and TRA-1-60 st
yellow dashed lines. Scale bars represent 100 μm. (F–I) Representati
splitting SSEA3+TRA-1-60+-containing cultures maintained in RM (Pas
iPSC-like colony is indicated with red dashed oval. Scale bars represe
60+ cells in RM versus MEFCM cultures after two passages (P2–4). Ba
comparison of RFLP signature obtained for parent hFib and associa
OCT4 in iPSCOCT4. (M) Flow cytometric analysis of non-transduced p
OCT4, SOX2, and NANOG.stabilization of pluripotency and enabled colony expansion
within two passages as evidenced by restoration of standard
PSC culture morphology and a significant increase in frequency
of SSEA3+ and TRA-1-60+ cells as compared to the culture
concurrently maintained in RM (Figs. 1F–J). Given their
morphological features and robust expression of
pluripotency-associated markers, we termed these cells
iPSCOCT4.
In an effort to ensure that iPSCOCT4 colony generation was
attributed to ectopic expression of OCT4 we generated
restriction fragment length polymorphism (RFLP) signatures
of iPSCOCT4 and compared them to that of the starting hFib
populations (Figs. 1K and S1G) confirming that iPSCOCT4
generation was not a result of culture cross contamination
with existing PSC lines from our lab. Furthermore, polymer-
ase chain reaction (PCR) analysis performed on genomic
DNA isolated from iPSCOCT4 colonies revealed the exclusive
presence of OCT4 provirus integration (Fig. 1L), indicating
that iPSCOCT4 were derived from hFibOCT4. To confirm that
the formation of iPSC colonies was directly correlated to
ectopic expression of OCT4 alone we used flow cytometric
analysis to assess pluripotent marker expression in
non-transduced, parent hFibs. These analyses revealed no
expression of endogenous OCT4, SOX2, or NANOG (Fig. 1M),
indicating that iPSCOCT4 generation was attributed to
OCT4-induced plasticity induction, and not due to OCT4
expression in combination with endogenous pluripotent TF
expression as previously demonstrated in neural progenitors
(Kim et al., 2009). Together, these data confirm that
iPSCOCT4 are derived from plastic OCT4-expressing adult
human fibroblasts.iPSCOCT4 possess biomolecular, immunophenotypic
and functional characteristics similar to iPSCOSNL
We next sought to further validate the pluripotent features
of iPSCOCT4 through comparison to iPSC generated previously
in our lab using a multi-factor approach (iPSCOSNL) (Hong et
al., 2011). To assess the expression of core pluripotency
factors OCT4, SOX2, and NANOG (Orkin et al., 2008), cul-
tures of iPSCOCT4 and iPSCOSNL with comparable confluence
and undifferentiated cell content (Fig. 2A) were collected
for gene expression and flow cytometric analyses. Endoge-
nous expression of OCT4, as well as activation of endogenousripotent supportive conditions is sufficient for the generation of
RM for 24 days. The presence of regions (red dashed circle and
g to hematopoietic culture conditions and undergoing direct
been induced. Scale bars represent 100 μm. (B) Flow cytometric
ce of CD45+ cells and the absence of SSEA3+ and TRA-1-60+ cells.
e, red dashed circle) and its subsequent expansion in its well of
enter image, red dash rectangle) is depicted in the image on the
of hFibOCT4 cultures possessing iPSC-like colonies reveals the
aining of iPSC-like colonies. Colony borders are indicated with
ve images and flow cytometric analyses of cultures derived from
sage 2, P2) into (F,G) RM or (H,I) MEFCM for two passages (P2-4).
nt 100 μm. (J) Comparison of frequencies of SSEA3+ and TRA-1-
rs represent n = 3 mean + SEM, **p b 0.005. (K) Representative
ted iPSCOCT4. (L) PCR showing exclusive genomic integration of
arent hFibs depicting the absence of endogenous expression of
226 K.R. Salci et al.SOX2 and NANOG transcripts, was observed in both iPSC lines
(Fig. 2B); demonstrating that exogenous OCT4-mediated
reprogramming is capable of activating pluripotent markers
similar to multi-factor approaches used for pluripotent re-
programming (Chan et al., 2009). Furthermore, in three
iPSCOCT4 lines derived from three separate human donors,
OCT4 transgene expression was decreased relative to FibOCT4and provided minimal contribution to total OCT4 expression
similar to that observed in iPSCOSNL (Yu et al., 2007) and
iPSCOSKM (Chan et al., 2009; Takahashi et al., 2007) (Fig. 2C).
At the protein level, flow cytometric analyses revealed that
activated expression of OCT4, SOX2, and NANOG, and
expression of SSEA3 and TRA-1-60 cell surface pluripotent
markers was similar between iPSCOCT4 vs iPSCOSNL cultures
227Acquisition of pluripotency in OCT4-plastic Fibsmaintained at comparable undifferentiated colony densities
(Figs. 2A and D); this protein-level pluripotent marker
expression was also observed in lower colony-density
cultures of additional iPSCOCT4 lines derived from indepen-
dent hFib sources (Fig. S1F). Together, these molecular and
phenotypic characteristics possessed by three independent
iPSCOCT4 lines are consistent with “type III” bona fide iPSCs
(Chan et al., 2009). Next, we used array comparative
genomic hybridization to assess the karyotype of three
independent iPSCOCT4 lines, at a genomic resolution beyond
that obtained using standard cytogenetic procedures (Elliott
et al., 2010; Martins-Taylor et al., 2011). One iPSCOCT4 line
was devoid of copy number variation (Fig. 2E), while the
others possessed two and five amplifications, the majority of
which are found in regions/chromosomes that are recur-
rently altered in cultured hPSCs (Fig. S3A) (Baker et al.,
2007; Martins-Taylor et al., 2011; Taapken et al., 2011).
While these results indicate that iPSCOCT4 reprogramming is
not dependent on the presence or acquisition of genetic
abnormalities to initiate pluripotency and is similar to OSKM
and OSNL pluripotent reprogramming (Martins-Taylor et al.,
2011; Takahashi et al., 2007; Yu et al., 2007), it is possible
that the incidence of genetic abnormalities may be in-
creased due to prolonged culture required for pluripotency
acquisition using OCT4 alone. Together these results demon-
strate that iPSCOCT4 possess the biomolecular hallmarks of
pluripotency similar to iPSCs generated using a multi-factor
reprogramming approach.
Themost stringent test for evaluating pluripotency of human
cells is the in vivo teratoma formation assay (Thomson et al.,
1998). To evaluate whether activation of the core pluripotent
network conferred functional pluripotent differentiation ca-
pacity in iPSCOCT4, we assessed their ability to generate tera-
tomas consisting of tissue derivatives from the three germ
layers (ectoderm, endoderm, and mesoderm) in immune
deficient mice. Cultures of iPSCOCT4 and iPSCOSNL, with com-
parable confluence and undifferentiated cell content based on
morphological observation and SSEA3 expression (Figs. S3B and
C), were prepared for intratesticular injection. Consistent with
bona fide PSC potential, both iPSCOCT4 and iPSCOSNL formed
teratomas comprised of all three germ layers (Figs. 2F and S3DFigure 2 iPSCOCT4 possess biomolecular, immunophenotypic and fu
images of established iPSCOCT4 and iPSCOSNL cultures prior to molecula
with yellow dashed lines. Scale bars represent 100 μm. (B) RT-qPCR
in whole iPSCOCT4 (P10) and iPSCOSNL (P52) cultures. Bars represen
expression is normalized to GAPDH and compared relative to hFibs. (C
in FibOCT4, Fib, and TRA-1-60+iPSCOCT4 (P12-19). Bars represent
expression is normalized to GAPDH and relative to FibOCT4. (D) Repr
expression in iPSCOCT4 and iPSCOSNL cultures. (E) Karyotype of iPSCOC
copy number variation. (F) Hematoxylin and eosin staining of teratom
layers. Tissue type is denoted, and associated area of interest is high
of EBs formed in vitro from iPSCOCT4 and iPSCOSNL, scale bars represe
and CD45 cell surface marker expression on dissociated, day 16 EBs d
cells at day 16 of hematopoietic differentiation, as assessed by flow
significantly different. (J) The frequency of CD34+CD45+ cells that g
represent n = 3 + SEM, results are not significantly different. (K) Dis
CFU assay. Bars represent n ≥ 4 + SEM. (L,M) Representative imag
Wright staining) generated from iPSCOCT4 and iPSCOSNL-derived EBs su
scale bars represent 10 μm.and E) indicating that iPSCOCT4 are functionally pluripotent in
vivo.
In addition to in vivo differentiation potential, we further
investigated if iPSCOCT4 were capable of responding to tar-
geted in vitro differentiation conditions. Based on our estab-
lished competencies in hematopoietic differentiation of PSCs
(Chadwick et al., 2003; Hong et al., 2010), we vigorously
assessed the in vitro hematopoietic capacity of iPSCOCT4. Using
an embryoid body (EB) based differentiation assay (Fig. 2G)
(Chadwick et al., 2003), cultures of iPSCOCT4and iPSCOSNL were
assessed for their ability to generate CD34+CD45+ hematopoi-
etic progenitors. Both iPSCOCT4 and iPSCOSNL underwent
differentiation toward the hematopoietic lineage, generating
similar frequencies of CD34+CD45+ putative hematopoietic
progenitors (Figs. 2H and I). To further characterize the
resulting putative hematopoietic progenitors and evaluate
whether they shared similar functional capacity to differenti-
ate into mature hematopoietic cells we subjected them to
colony forming unit (CFU) assays. The frequency of CD34+CD45+
progenitors with CFU potential was similar between blood
progenitors derived from iPSCOCT4 and iPSCOSNL (Fig. 2J).
Moreover, both iPSCOCT4 and iPSCOSNL derived progenitors
displayed multilineage differentiation into all of the mature
hematopoietic cell types read out by the CFU assay (Fig. 2K),
which was further confirmed by Giemsa-Wright assessment of
single cell morphologies (Figs. 2L and M). Taken together these
results confirm that like iPSCOSNL, iPSCOCT4 are capable of
responding to targeted differentiation cues resulting in the
generation of mature tissue types in vitro, further validating
this unique source of pluripotent stem cells.Discussion
Here we show that continued (albeit prolonged) culture of
plastic hFibOCT4 in RM media is sufficient for induction of
pluripotency. Importantly, iPSCOCT4 possess morphological,
biomolecular, and functional hallmarks of bona fide PSCs (K.R.
Salci et al., 2015). Building on our previous works using OCT4 to
induce a state of plasticity required for cell fate conversion (R.
Mitchell et al., 2014; R. R. Mitchell et al., 2014; Szabo et al.,nctional characteristics similar to iPSCOSNL.(A) Representative
r and phenotypic characterization. Colony borders are indicated
data examining endogenous OCT4, SOX2, and NANOG expression
t mean + standard deviation, n = 3 technical replicates; gene
) RT-qPCR data examining total and exogenous OCT4 expression
mean + standard deviation, n = 3 technical replicates; gene
esentative flow cytometric analysis plots of pluripotent marker
T4 (P19), generated by aCGH analysis, depicting the absence of
a sections depicting cell derivatives of all three embryonic germ
lighted by either red circle or arrow. (G) Representative images
nt 100 μm. (H) Representative flow cytometric analyses of CD34
erived from iPSCOCT4 and iPSCOSNL. (I) Frequency of CD34+CD45+
cytometric analysis. Bars represent n = 3 + SEM, results are not
ive rise to colony forming units when plated in CFU assay. Bars
tribution of hematopoietic colony types formed by day 16 of the
es of mature hematopoietic colonies (and associated Giemsa–
bjected to CFU assay. White scale bars represent 100 μm, black
Figure 3 Acquisition of pluripotency is one of multiple cell fate choices that can be facilitated through environmental stimulation
of OCT4 induced plasticity. Schematic placing the derivation of iPSCOCT4 from plastic cells into context with previous demonstrations
of cell fate conversion using OCT4 plastic cells. Given the stochastic nature of cellular fate reprogramming of adult human primary
tissues, the range in timing of observed OCT4-induced plasticity events is illustrated by dotted bar lines along the timeline.
228 K.R. Salci et al.2010), our current findings highlight that pluripotency repre-
sents another cell fate choice for plastic human fibroblasts
(Fig. 3) and provides further example that cell fate alteration
through plasticity induction can be achieved without additional
TFs (Efe et al., 2011; Kim et al., 2011; Li et al., 2013) or small
molecules (Wang et al., 2014; Zhu et al., 2014).
Despite the myriad of methodologies to induce pluripotency
in human somatic cells (Anokye-Danso et al., 2011; Buganim et
al., 2014; Eminli et al., 2008; Giorgetti et al., 2009; Heng et al.,
2010; Hou et al., 2013; Kim et al., 2009; Li et al., 2011;
Montserrat et al., 2013; Nakagawa et al., 2008; Redmer et al.,
2011; Shu et al., 2013; Takahashi et al., 2007; Theunissen and
Jaenisch, 2014; Yu et al., 2007; Zhu et al., 2010), exogenous
delivery or endogenous activation of OCT4 is indispensible for
reprogramming to pluripotency. Furthermore, we are unaware
of any report suggesting that iPSCs can be generated without
the use of pluripotent-supportive reprogramming media. As
we have demonstrated that pluripotency is another destination
of plastic human fibroblasts, we suggest that conventional
reprogramming to pluripotency (Takahashi et al., 2007; Yu et
al., 2007) relies on the combination of OCT4-induced plasticity
and pluripotent media instruction, and is expedited or further
specified by the addition of pluripotent-specifying TFs (SKM,
SNL). We also propose that this could explain why pluripotency
is transiently acquired during OSKM-mediated “transdiffer-
entiation” (Maza et al., 2014). Given the reduced complexity
of our reprogramming system, we feel OCT4 -induced plasticity
represents an ideal model to elucidate the governing mecha-
nisms that allow for alteration of cell fate upon manipulation of
native transcriptional programs toward both lineage specific
progenitors and pluripotent stem cells alike.
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